INTRODUCTION
Preexposure prophylaxis (PrEP) has been shown to be very effective in preventing HIV acquisition when taken consistently. [1] [2] [3] High adherence in the absence of HIV risk, however, may lead to unnecessary financial or emotional burden or, rarely, side effects for the PrEP user, as well as unnecessary expenditures for the healthcare system. 4 These considerations have likely contributed to the slow roll-out of PrEP in many settings. 5 PrEP adherence should, therefore, be aligned with periods of substantial HIV risk, with options for temporary or permanent discontinuation when risk is minimal-a concept known as prevention-effective adherence. 4 Traditional methods for understanding dynamic HIV acquisition risk behaviors and concurrent use of HIV prevention strategies are limited. Typically, these data are collected at infrequent intervals (eg, quarterly study visits), which may be subject to recall bias. 6 Moreover, social desirability bias may limit reporting accuracy on these sensitive topics, particularly when assessed face-to-face. Novel, real-time approaches are therefore needed to understand the context in which PrEP adherence is (or is not) occurring.
Approximately 5 billion people own mobile phones globally, making them a potentially valuable tool for selfreported data collection. 7 Kenya, for example, had 33.6 million mobile phone subscribers in 2014 (reflecting 83% country penetration), with short message service (SMS) preferred to voice calls. 8 SMS enables frequent, inexpensive surveys that could potentially overcome the recall and social desirability biases inherent in traditional data collection. 9, 10 Moreover, preliminary work has shown SMS surveys to be feasible and acceptable for collection of antiretroviral adherence and sexual behavior data. 11, 12 In this paper, we describe the use of SMS surveys for determining prevention-effective adherence among HIV serodiscordant couples enrolled in a demonstration project of antiretroviral-based prevention in East Africa.
METHODS

The Partners Demonstration Project
The Partners Demonstration Project was a prospective, open-label study of integrated ART and PrEP delivery for HIV prevention among high-risk heterosexual HIV serodiscordant couples in Kenya and Uganda. Study procedures are detailed elsewhere. 13 Briefly, eligible couples were $18 year old, sexually active, and intending to remain a couple for $1 year. HIV-uninfected partners were offered once daily oral PrEP (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) with use recommended until the partner living with HIV had been on ART for $6 months, permitting time to achieve viral suppression (a strategy called "PrEP as a bridge to ART"). The PrEP "bridge" period could be extended for couples in which the partner living with HIV delayed or declined ART or if the HIV-uninfected partner and/or clinician felt there was other rationale to continue. Study visits occurred at 1 month and quarterly for up to 24 months. Counseling messages were consistent with the US Center for Disease Control guidance, 14 including daily PrEP use. 15 The Partners Mobile Adherence to PrEP (PMAP) Substudy
The Partners Mobile Adherence to PrEP (PMAP) substudy was designed to assess PrEP adherence and concurrent risk for HIV acquisition via SMS surveys and was implemented at 2 study sites (Thika and Kampala). HIVnegative partners were eligible if they had $3 months of planned PrEP use, owned a mobile phone using a service provider compatible with the SMS platform (ie, Safaricom in Thika; MTN and Airtel in Kampala), were literate, able to receive and send SMS, and had regular access to electricity for charging their phone. Eligible participants completed a 1-week trial period of daily surveys and were enrolled if they completed $3 daily surveys; additional training was provided as needed.
Participants were sent daily SMS surveys for 7 days before and 7 days after each study visit in the Partners Demonstration Project (the "reporting window"). Surveys were sent at participant-selected times and were available for responses for 23 hours after delivery. Each survey was initiated only after receipt of a 4-digit password and consisted of 7 questions with branching logic on sexual activity and PrEP adherence in the previous 24 hours (Supplemental Digital Content, http://links.lww.com/QAI/B82). Depending on survey skip patterns, Questions about general health behaviors (eg, drinking boiled water) were used to ensure each survey consisted of 7 questions, thus discouraging responses leading to shorter surveys. Participants were incentivized with approximately US$0.50 of airtime for each completed survey, which was automatically delivered to their phones. SMS surveys were sent while participants were eligible to take PrEP, and held during protocol-defined holds (eg, drug toxicity). During prolonged cellular network outages, additional SMS surveys were sent to affected participants, so approximately 14 surveys were sent around each study visit.
Statistical Analysis
Participant characteristics and survey responses were summarized. Sexual activity and PrEP adherence were assessed at the level of the survey. Average adherence was calculated per participant using the number of days on which adherence was reported, divided by the number of days for which SMS survey data were available. Adherence was then stratified by days reporting or not reporting sex, and averaged over the study period. Data were limited to periods when PrEP was dispensed. ART use by partners living with HIV was obtained from Partners Demonstration Project records. HIV-uninfected partners were considered at risk for HIV if they had condomless sex within the serodiscordant partnership while the partner living with HIV had taken ART for ,6 months. Wilcoxon rank sum and x 2 tests were used for comparisons of continuous and categorical variables, respectively. Comparisons were performed within each individual using a fixed effects model to control for time-invariant confounding. Differences were also assessed by biological sex and compared before and after study visits.
Ethics Statement
All participants provided written informed consent. Institutional review board approval was obtained from Partners Healthcare/Massachusetts General Hospital, the University of Washington, the Kenyan Medical Research Institute, and the Uganda National Council for Science and Technology.
RESULTS
PMAP Participant Characteristics
The Thika and Kampala sites contributed 332 and 292 participants, respectively, to the Partners Demonstration Project (total N = 624). Twenty-seven participants were lost to follow-up and could not be approached for participation in PMAP. Of the 597 screened, 6 declined, 68 were not planning $3 months of PrEP use at screening, and 150 were found ineligible for other reasons: 77 were illiterate/unable to read or send SMS; 49 lacked a functional, personal mobile phone on a compatible service provider, and 24 failed the SMS survey trial. Some individuals had multiple reasons for ineligibility. A total of 373 individuals enrolled in PMAP.
Sixty-nine percent of PMAP participants were men with a mean age of 31 [standard deviation (SD) 8] years and 10 (SD 3) years of education. Condomless sex was reported in the month before enrollment by 68%. Site differences in participant characteristics are shown in the Table 1 .
SMS Surveys
A total of 23,056 SMS surveys were sent during the PMAP study, of which 17,030 (74%) were completed by 359 participants. A mean of 47 (SD 29) SMS surveys were completed per participant over a mean of 4.6 (SD 2.2) 14-day reporting windows, reflecting a mean of 9.8 (SD 6.0) months of study participation. Differences in SMS surveys between the study sites are shown in Table 1 ; participants in Thika completed more surveys and reported more PrEP use, more days with sex, and more condom use. Data on sex, condom use, and PrEP adherence were missing from 46, 67, and 93 surveys, respectively. Of note, mid-way through the study, a Ugandan national telecommunication policy aimed at limiting undesired bulk SMS 16 temporarily disrupted SMS delivery, resulting in $3 weeks of missed surveys for participants in the Kampala site and permanent termination for 13 participants who only had access to the service provider, Airtel.
Prevention-Effective Adherence
Overall mean adherence to PrEP without regard to other behaviors was reported as 80% (SD 25). As shown in Figure 1 , 305 participants completed 9,765 surveys while their partner living with HIV had taken ART for ,6 months. Sex within the serodiscordant partnership in the previous 24 hours was reported by 344 participants on 5542 surveys, and 206 participants reported lack of condom use on 1325 of these surveys. Considered concurrently, condomless sex within the serodiscordant partnership while the partner living with HIV had used ART for ,6 months (the definition of HIV risk in this analysis) was reported by 147 participants on 745 surveys (4% of all completed surveys). PrEP adherence was reported on 89% (SD 26) of these surveys indicating HIV risk (P , 0.001 compared with 80% PrEP adherence among all other surveys). No differences were seen when comparing average or prevention-effective adherence before and after study visits, although condom use increased by 4% after the study visit (P = 0.013). One PMAP participant was found to have HIV at Month 3; SMS-reported adherence was 67% around that visit.
Differences in PrEP Adherence by Reported Risk
While the partner living with HIV had taken ART for ,6 months, mean PrEP adherence was higher on the 3266 surveys reporting sex (regardless of condom use) versus the 6453 surveys not reporting sex (92% versus 84%, P , 0.001), although PrEP adherence when reporting sex was lower in the 709 surveys completed by women compared with the 2464 surveys completed by men (87% versus 94%, P = 0.019). Mean PrEP adherence was similar for the 2454 surveys reporting condom use versus the 745 not reporting condom use (93% versus 89%, P = 0.24).
DISCUSSION
Periodic daily SMS surveys provided real-time assessment of concurrent PrEP adherence and sexual behavior in a demonstration project of antiretroviral-based prevention among HIV serodiscordant couples in East Africa. Data show that overall self-reported SMS adherence was high at 80%. Other adherence measures from the Partners Demonstration Project were similarly high: electronic monitoring indicated that PrEP was taken on 82% of expected days and tenofovir was detected in plasma in 85% of randomly selected samples. 13 Overall incidence of HIV infection was 0.2 per 100 person-years, further suggesting that participants adhered to PrEP and/or ART during periods of risk for HIV acquisition.
SMS data in this analysis also show that adherence was higher when reporting versus not reporting sex before 6 months of ART use by the partner living with HIV (92% versus 84%), although adherence with reported sex was somewhat lower in women compared to men participants (87% versus 94%). In the Partners PrEP study, plasma tenofovir concentrations were similarly detected more often in individuals reporting versus not reporting sex. 17 This difference suggests that participants adjusted their use of PrEP based on sexual activity and perceived risk. Participants were counseled to take PrEP daily to achieve effective protection against HIV infection; however, they were also advised on risk of HIV acquisition and the protection that was achievable through other tools (eg, sexual abstinence, condoms). Individuals may have chosen to take PrEP based on perceived risk when considering these other factors.
This study presents risk data obtained daily; however, it is important to note that the need for PrEP should not be assessed day-to-day. Pharmacokinetic data suggest that individuals should take several daily doses upon PrEP initiation to achieve steady-state tenofovir levels in blood and longer in tissue compartments, ranging from a few days for men who have sex with men to 1-3 weeks in women. 18, 19 Additionally, risk for HIV acquisition may be difficult to anticipate. 20 Risk assessment over longer periods or "seasons" is more likely to be accurate and useful when assessing prevention-effective adherence. 4 These findings highlight the importance of understanding PrEP adherence patterns and formulating counseling messages that help people regulate their own adherence in ways that provide maximal protection against HIV acquisition when needed, including choice among PrEP and other HIV prevention options. SMS surveys were feasible for assessing PrEP use and concurrent HIV risk, although completion rates were lower in Kampala compared with Thika. The temporary disruption caused by national Ugandan telecommunications policy was partially contributory. Additionally, although not formally measured, power outages were more common in Kampala, potentially limiting the ability to charge phones. Given wide availability of mobile phones and relatively low cost of SMS, this tool should be considered for future studies and potential clinical practice. Clinics, for example, could send weekly surveys to help PrEP users assess their risk and use of PrEP, as well as provide support if needed. This approach was used previously with ART delivery in Kenya 21 and showed improved ART adherence and viral suppression. Provision of real-time feedback on adherence is another potential use of this technology and appears favorable to PrEP users. 22 Our study has limitations. First, SMS reports may still be influenced by recall and/or social desirability bias, as seen previously. 12 The adherence reported by the 1 PMAP participant who acquired HIV during the study was suboptimal (67%), but may still have been an overestimate. Differences in adherence and sexual behavior between biological sexes or study sites may thus reflect true differences in behavior and/or differences in reporting behavior. Second, while only 6 individuals declined study participation, 34% of surveys were not completed. It is unknown if these data were missing at random or reflected changes in behavior (eg, not wanting to report nonadherence). Behavior may have also varied in between reporting windows or because of the timing of the study visit. We found no difference when comparing adherence before and after study visits, although condom use did increase slightly (4%). Third, this study did not assess all potential risk factors associated with HIV acquisition, such as outside partnerships and concurrent sexually transmitted infections. Fourth, the SMS may have served as reminders and increased adherence.
In conclusion, periodic daily SMS surveys provided concurrent, real-time reports of sexual behavior and PrEP adherence within HIV serodiscordant couples that indicate high levels of alignment for PrEP adherence and risk for HIV acquisition. These data and reports of high adherence for PrEP elsewhere 23, 24 are encouraging that PrEP adherence among individuals who desire it will be high enough to realize effective HIV prevention outside of clinical trials.
